Driving The Expansion Of mRNA Into The Therapeutic Sphere

The success of mRNA-based COVID-19 vaccines has paved the way for a revolutionary expansion of this technology across the advanced therapies landscape, particularly in major disease areas like oncology. While preclinical and early clinical studies show tremendous promise, significant challenges in scale-up and characterization still need to be addressed to fully unlock its potential.

This expert panel offers a high-level perspective on the ever-expanding reach of mRNA technology, detailing where its next major therapeutic impacts will be felt. The discussion then shifts to the core technical hurdles, providing a critical assessment of remaining challenges in mRNA processing, with a focus on downstream purification, and supply chain logistics. Gain essential insights into new and emerging technologies and process innovations that are poised to improve the safety and efficacy profiles of the next generation of mRNA therapeutics.

Watch the full webinar to explore expert R&D analysis and practical solutions for advanced mRNA manufacturing.